NCT01394341View on ClinicalTrials.gov

Liraglutide Treatment to Patients With Severe Renal Insufficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Type 2 Diabetes MellitusEnd-stage Renal Disease
Interventions
DRUG

Liraglutide

Daily sc. injection, individual dosage

Trial Locations (3)

2100

Department of Endocrinology PE, Copenhagen University Hospital, Rigshospitalet, Copenhagen Ø

Department of Nephrology P, Copenhagen University Hospital, Rigshospitalet, Copenhagen Ø

3400

Department of Internal Medicine H, Hillerød Hospital, Hillerød

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

The GCP unit at Copenhagen University Hospital

UNKNOWN

lead

Bo Feldt-Rasmussen

OTHER